Delivery Order SPE2DB22D1202-SPE2DB25FUGJ7

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,586.14, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price pricing type. The award supports the procurement of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with an ultimate completion date of January 16, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,171.53 firm fixed-price delivery order is for the supply of 4562350499 - ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of October 2, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The award, valued at $5,586.93, is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ATOVAQUONE-PROGUANIL 250-100 UD 24S medical products. The delivery order has a ceiling value of $9,033.83 and an ultimate completion date of December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,795.26 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $11,233.75 for the supply of 4564616272 ! ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major component of the Department of Defense (DoD) responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces. Amerisourcebergen, a large pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,234.23, is for the delivery of Atovaquone-Proguanil 250-100 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 29, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,272.60 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,760.51 Firm Fixed Price Delivery Order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of October 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,707.42 Firm Fixed Price Delivery Order is for the supply of 4566369418 - ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The award has an ultimate completion date of November 8, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUGJ7
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $10,386.24 for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 25, 2024. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. The deliveries will be made to Conshohocken, PA.

Generated 1/23/25, 9:37 AM